Literature DB >> 25081543

The transcription factor MEF/Elf4 is dually modulated by p53-MDM2 axis and MEF-MDM2 autoregulatory mechanism.

Mary Ann Suico1, Ryosuke Fukuda2, Rui Miyakita2, Kosuke Koyama2, Manabu Taura2, Tsuyoshi Shuto2, Hirofumi Kai2.   

Abstract

Myeloid Elf-1-like factor (MEF) or Elf4 is an ETS transcription factor that activates innate immunity-associated genes such as lysozyme (LYZ), human β-defensin 2 (HβD2), and interleukin-8 (IL-8) in epithelial cells and is also known to influence cell cycle progression. MEF is transcriptionally activated by E2F1, but the E2F1-mediated transcriptional activation is inhibited by p53 through E2F1-p53 protein interaction. Although the transcriptional activation of MEF has been investigated in depth, its post-translational regulation is not well explored. By overexpressing MEF cDNA in human cell lines, here we show that MEF protein expression is suppressed by p53. By screening a number of E3 ligases regulated by p53, we found that MDM2 is involved in the effect of p53 on MEF. MDM2 is transcriptionally activated by p53 and interacts with MEF protein to enhance MEF degradation. MDM2 reduces MEF protein expression, as well as stability and function of MEF as transcriptional activator. Furthermore, MDM2 was able to down-regulate MEF in the absence of p53, indicating a p53-independent effect on MEF. Notably, MEF transcriptionally activates MDM2, which was previously demonstrated to be the mechanism by which MEF suppresses the p53 protein. These results reveal that in addition to the potential of MEF to down-regulate p53 by transcriptionally activating E3 ligase MDM2, MEF participates with MDM2 in a novel autoregulatory feedback loop to regulate itself. Taken together with the findings on the effect of p53 on MEF, these data provide evidence that the p53-MDM2-MEF axis is a feedback mechanism that exquisitely controls the balance of these transcriptional regulators.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ETS Transcription Factor Family; Mouse Double Minute 2 Homolog (MDM2); Myeloid Elf-1-like Factor/Elf-4; Protein Degradation; Transcription Factor; p53

Mesh:

Substances:

Year:  2014        PMID: 25081543      PMCID: PMC4176203          DOI: 10.1074/jbc.M114.580209

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells.

Authors:  H Daniel Lacorazza; Yasushi Miyazaki; Antonio Di Cristofano; Anthony Deblasio; Cyrus Hedvat; Jin Zhang; Carlos Cordon-Cardo; Shifeng Mao; Pier Paolo Pandolfi; Stephen D Nimer
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

2.  p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines.

Authors:  Manabu Taura; Ayaka Eguma; Mary Ann Suico; Tsuyoshi Shuto; Tomoaki Koga; Kensei Komatsu; Takefumi Komune; Takashi Sato; Hideyuki Saya; Jian-Dong Li; Hirofumi Kai
Journal:  Mol Cell Biol       Date:  2008-09-08       Impact factor: 4.272

Review 3.  The oncogenic role of the ETS transcription factors MEF and ERG.

Authors:  Goro Sashida; Elena Bazzoli; Silvia Menendez; Yan Liu; Stephen D Nimer
Journal:  Cell Cycle       Date:  2010-09-13       Impact factor: 4.534

Review 4.  Modifications of p53: competing for the lysines.

Authors:  Stephanie Carter; Karen H Vousden
Journal:  Curr Opin Genet Dev       Date:  2009-02       Impact factor: 5.578

5.  The ETS protein MEF is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2.

Authors:  Yan Liu; Cyrus V Hedvat; Shifeng Mao; Xin-Hua Zhu; Jinjuan Yao; Hoang Nguyen; Andrew Koff; Stephen D Nimer
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

6.  Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation.

Authors:  Yong-Sam Jung; Gang Liu; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2009-12-14       Impact factor: 4.272

7.  The Many Faces of MDM2 Binding Partners.

Authors:  Maurisa F Riley; Guillermina Lozano
Journal:  Genes Cancer       Date:  2012-03

8.  Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53.

Authors:  F Hoppe-Seyler; K Butz
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

9.  Myeloid ELF1-like factor is a potent activator of interleukin-8 expression in hematopoietic cells.

Authors:  Cyrus V Hedvat; JinJuan Yao; Robert A Sokolic; Stephen D Nimer
Journal:  J Biol Chem       Date:  2003-11-17       Impact factor: 5.157

10.  Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection.

Authors:  Jan Lehmann; Margitta Retz; Jürgen Harder; Matthias Krams; Udo Kellner; Julia Hartmann; Kerstin Hohgräwe; Uta Raffenberg; Martin Gerber; Tillmann Loch; Klaus Weichert-Jacobsen; Michael Stöckle
Journal:  BMC Infect Dis       Date:  2002-09-18       Impact factor: 3.090

View more
  8 in total

1.  ELF4 Is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State.

Authors:  Adam Kosti; Liqin Du; Haridha Shivram; Mei Qiao; Suzanne Burns; Juan Gabriel Garcia; Alexander Pertsemlidis; Vishwanath R Iyer; Erzsebet Kokovay; Luiz O F Penalva
Journal:  Mol Cancer Res       Date:  2019-10-17       Impact factor: 5.852

2.  Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome.

Authors:  Tsubasa Yokota; Kohei Omachi; Mary Ann Suico; Haruka Kojima; Misato Kamura; Keisuke Teramoto; Shota Kaseda; Jun Kuwazuru; Tsuyoshi Shuto; Hirofumi Kai
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

Review 3.  Roles and regulations of the ETS transcription factor ELF4/MEF.

Authors:  Mary Ann Suico; Tsuyoshi Shuto; Hirofumi Kai
Journal:  J Mol Cell Biol       Date:  2017-06-01       Impact factor: 6.216

4.  A novel condition of mild electrical stimulation exerts immunosuppression via hydrogen peroxide production that controls multiple signaling pathway.

Authors:  Mariam Piruzyan; Ihori Shitanda; Yuichiro Shimauchi; Go Okita; Yu Tsurekawa; Masataka Moriuchi; Yoshio Nakano; Keisuke Teramoto; Mary Ann Suico; Tsuyoshi Shuto; Hirofumi Kai
Journal:  PLoS One       Date:  2020-06-22       Impact factor: 3.240

5.  The role of discoidin domain receptor 2 in the renal dysfunction of alport syndrome mouse model.

Authors:  Yuya Sannomiya; Shota Kaseda; Misato Kamura; Hiroshi Yamamoto; Hiroyuki Yamada; Masataka Inamoto; Jun Kuwazuru; Saki Niino; Tsuyoshi Shuto; Mary Ann Suico; Hirofumi Kai
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

6.  High ELF4 expression in human cancers is associated with worse disease outcomes and increased resistance to anticancer drugs.

Authors:  Doris Kafita; Victor Daka; Panji Nkhoma; Mildred Zulu; Ephraim Zulu; Rabecca Tembo; Zifa Ngwira; Florence Mwaba; Musalula Sinkala; Sody Munsaka
Journal:  PLoS One       Date:  2021-04-09       Impact factor: 3.240

7.  High throughput data analyses of the immune characteristics of Microtus fortis infected with Schistosoma japonicum.

Authors:  Yuan Hu; Lei Sun; Zhongying Yuan; Yuxin Xu; Jianping Cao
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

8.  Mild electrical stimulation with heat shock attenuates renal pathology in adriamycin-induced nephrotic syndrome mouse model.

Authors:  Keisuke Teramoto; Yu Tsurekawa; Mary Ann Suico; Shota Kaseda; Kohei Omachi; Tsubasa Yokota; Misato Kamura; Mariam Piruzyan; Tatsuya Kondo; Tsuyoshi Shuto; Eiichi Araki; Hirofumi Kai
Journal:  Sci Rep       Date:  2020-10-30       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.